CMC Requirements for New Drug Registration in Latin America
ISPE
MAY 9, 2023
The information required in these declarations include product information (name, strength, dosage form), manufacturer, packager and license holder, and drug product manufacturing site name and country. In addition, a method transfer protocol and report also need to be generated and included in the dossier, as appropriate.
52 
Let's personalize your content